171 related articles for article (PubMed ID: 4578936)
1. The chemotherapy of rodent malaria. 18. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 5. The blood schizontocidal action of some newer sulphonamides.
Peters W
Ann Trop Med Parasitol; 1973 Jun; 67(2):155-67. PubMed ID: 4578936
[No Abstract] [Full Text] [Related]
2. The chemotherapy of rodent malaria. XIV. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 4. The response of normal and drug-resistant strains of Plasmodium berghei.
Peters W
Ann Trop Med Parasitol; 1971 Jun; 65(2):123-9. PubMed ID: 5090256
[No Abstract] [Full Text] [Related]
3. The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, 2: schizontocidal action in the albino mouse.
Peters W
Annu Rev Pharmacol; 1968 Dec; 62(4):488-94. PubMed ID: 5731727
[No Abstract] [Full Text] [Related]
4. The chemotherapy of rodent malaria, 8. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, part 3: the action of sulphormethoxine and pyrimethamine on the sporogonic stages.
Ramkaran AE; Peters W
Ann Trop Med Parasitol; 1969 Dec; 63(4):449-54. PubMed ID: 5384694
[No Abstract] [Full Text] [Related]
5. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.
Peters W
Ann Trop Med Parasitol; 1975 Jun; 69(2):155-71. PubMed ID: 1098584
[TBL] [Abstract][Full Text] [Related]
6. The chemotherapy of rodent malaria. VI. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. I. Introduction and anti-vector studies.
Beesley WN; Peters W
Ann Trop Med Parasitol; 1968 Sep; 62(3):288-94. PubMed ID: 5714956
[No Abstract] [Full Text] [Related]
7. The action of sulphonamide-folic reductase inhibitor combinations against normal and drug-resistant strains of rodent malaria.
Peters W
Trans R Soc Trop Med Hyg; 1971; 65(1):11-2. PubMed ID: 5559915
[No Abstract] [Full Text] [Related]
8. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
10. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
11. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.
Knight DJ; Peters W
Ann Trop Med Parasitol; 1980 Aug; 74(4):393-404. PubMed ID: 7006531
[No Abstract] [Full Text] [Related]
12. The chemotherapy of rodent malaria. XVII. Dynamics of drug resistance. 3. Influence of drug combinations on the development of resistance to chloroquine in P. berghei.
Peters W
Ann Trop Med Parasitol; 1973 Jun; 67(2):143-54. PubMed ID: 4578935
[No Abstract] [Full Text] [Related]
13. The mechanisms of drug resistance in malaria parasites.
Peters W
J Parasitol; 1971 Aug; 57(4):103-7. PubMed ID: 5001106
[No Abstract] [Full Text] [Related]
14. Antifolic combinations in the treatment of malaria.
Conno L
Bull World Health Organ; 1974; 50(3-4):223-30. PubMed ID: 4613504
[TBL] [Abstract][Full Text] [Related]
15. Differences in drug response of the sporogonous cycles of three strains of Plasmodium falciparum in Anopheles stephensi.
Terzian LA; Stahler N; Dawkins AT
Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):16-24. PubMed ID: 4400231
[No Abstract] [Full Text] [Related]
16. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
Tan-ariya P; Brockelman C
Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):7-11. PubMed ID: 6377515
[TBL] [Abstract][Full Text] [Related]
17. Biochemical aspects of drug action and resistance in malaria parasites.
Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening.
Peters W; Davies EE; Robinson BL
Ann Trop Med Parasitol; 1975 Sep; 69(3):311-28. PubMed ID: 1098590
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of Kelfizina-trimethoprim and Kelfizina-pyrimethamine versus chloroquine in field trials in Nigeria.
Donno L; Sanguineti V; Ricciardi ML; Soldati M
Am J Trop Med Hyg; 1969 Mar; 18(2):182-7. PubMed ID: 4888027
[No Abstract] [Full Text] [Related]
20. The drug response of a normal and a multi-resistant strain of P. falciparum to sulphalene.
Martin DC; Arnold JD
Trans R Soc Trop Med Hyg; 1968; 62(6):810-5. PubMed ID: 4891862
[No Abstract] [Full Text] [Related]
[Next] [New Search]
